The content on this site is intended for healthcare professionals only
Dr. Dieter Wallach, the managing director of Ergosign discusses the collaboration between Ergosign and Pmedicine in creating user interfaces for clinicians and patients. He also talks about the constraints that they have faced and the differences that a clinician or patient will see when using the tool.
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Synthetic biology and precision medicine in blood and gynaecological cancers
Early-stage breast cancer detection in breast milk
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Moving to the future: Artificial intelligence in surgery
